Grow Biotech, ECH and IPS Specials Facilitate First Batch of Medical Cannabis to UK for Multiple Patients
Ryan Allway
February 18th, 2019
News
LONDON, Feb. 15, 2019 /PRNewswire/ — Today, Grow Biotech, ECH and IPS Specials have made history by importing the first bulk shipment of cannabis-based medicines to the UK since the Home Office formally acknowledged the medical benefits of cannabis last November – marking a significant step forward for the fledgling British legal cannabis industry, while greatly improving the ease of access for patients.
British medical cannabis start-up Grow Biotech collaborated with IPS Specials and European Cannabis Holdings (ECH) to facilitate the import. Grow Biotech’s team of specialists made this possible by working alongside doctors to address their concerns regarding quality assurance and compliance for the prescriptions they have written, bridging the gap between existing cannabis medicines and accepted pharmaceutical standards.
The shipment has been exported by the Office of Medical Cannabis of the Netherlands and will be delivered directly to the patients from a pharmacy in the UK, with additional stock retained to ensure continuity of supply. The stock includes Bedrocan Flower Afina, and Bedica Flower Talea, which are used to treat a range of conditions including chronic pain and multiple sclerosis.
Dr. David McDowell, who sits on the ECH’s medical board said, “The fact that we are now in a position to write prescriptions that can actually be fulfilled is a huge achievement. Patients no longer need to worry about how they can access their medication, which will mark a positive step change in their journey and finally provide the relief that they are looking for, and we can now finally provide.”
This will lay the cornerstone for the British medical cannabis industry’s international supply chain and proves that challenging regulations can be adhered to through innovation and creativity.
Dr Henry Fisher, R&D Project Manager at Grow Biotech said: “We are building a team that will help take the UK medical cannabis industry’s infrastructure to the next stage, constructing a scalable and reliable system to meet patients’ needs and to support doctors’ understanding of medical cannabis as a potentially valuable treatment for particular conditions. Our aim is to encourage greater understanding of cannabis medicines in the UK.”
Ashok Patel, Founder and Executive Chairman of IPS Specials said, “If manufacturers and producers are willing to take a measured approach, we can and will continue to navigate a pathway for medical cannabis in the UK.”
Tony Dutta (IPS Specials), Dr Fisher and Hari Guliani from Grow Biotech are all available for interview.
About Grow Biotech
Grow Biotech is a British company developing revolutionary processes, techniques, tools and formulations to bridge the gap between existing cannabis medicines and accepted pharmaceutical standards.
About IPS Specials
IPS Specials is a pharmaceutical importer, distributor and manufacturer with over 17 years’ experience in unlicensed and licensed medicines.
About European Cannabis Holdings
ECH is shaping the future of legal cannabis while firmly entrenched at the forefront of the European industry. This unrivalled group of companies provides leadership, innovation and growth through a portfolio of companies that provide ECH with a fundamental anchor in the cannabis investment market, while helping it define this emerging industry.
Contact details
For any media-related inquiries please contact:
Grow Biotech Press Office | press@growbiotech.com
SOURCE Grow Biotech; ECH and IPS Specials
Related Links
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
The producers of O’ Cannabiz have decades of experience producing national-profile events and creating global connections between business communities in the arts, broadcasting, media and technology. They have organized trade summit initiatives with governments around the world. And they have worked closely with sponsors in all levels of Canadian government.
Tim has over 22 years of investment experience as a portfolio manager, asset allocator, and capital markets professional across multiple asset classes, geographies, and platforms. Tim has built and operated two hedge funds, a broker dealer, and raised over $1Bn in capital for his combined businesses. Tim remains a recognized voice within the investment community […]
Valens GroWorks is a multi-licensed, vertically integrated provider of Canadian cannabis products with two wholly-owned subsidiaries located in Kelowna, BC.
EuroMed Therapeutics is building the ninth Israeli licensed producer to capitalize on the domestic medical marijuana market and Europe’s nascent export market — worth upwards of $66 billion.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
